Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ASH2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WIPF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCTP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLITRK5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INMT-FAM188B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFI44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6778 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX60 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRTAP9-9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SEPT7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IQCE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAQR8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LOC401463 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928710 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATA17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HRASLS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAMLD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRTAP9-4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on